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Summary 
We have used an in vitro system to study the effects of major histocompatibility complex class 
I binding peptides on thymic development. Fetal thymus lobes from mice deficient in the class 
I light chain (~2 microglobulin or fl2M-/-) were cultured for 10 d in vitro, during which time 
T cell precursors develop into mature T cells. In these organ cultures, as in the adult or neonatal 
flzM-/-  thymus, CD8 + mature T cells did not develop, demonstrating that the mature T cells 
seen during early murine thymic development are the result of the positive selection process. 
To these cultures we added various class I binding peptides with or without a source of exogenous 
fl2M.  CD8 § T  cells developed to various degrees only in the presence of 32M and peptides. 
Using peptide mixtures of differing complexity, we showed that the efficiency of this process 
is dependent more on peptide complexity than on peptide concentration. These data argue for 
a specific role for peptides in the process of positive selection. Furthermore, this culture system 
should be useful in identifying peptides that can promote positive selection of cells expressing 
a specific T  cell receptor (TCR) in TCR transgenic mice. 
C 
D8  T  cells mature in the thymus and are subject to 
the processes of positive and negative selection during 
their  development  (1). The  process  of positive  selection, 
whereby T  cells with the capacity to recognize antigens in 
the context of the individual MHC molecules are rescued 
from programmed cell death, is known to require the inter- 
action of the TCR with MHC molecules on thymic stromal 
cells. It has been proposed that MHC-self-peptide complexes, 
as opposed to MHC molecules alone, mediate this event. This 
is quite likely to be the case since very few "empty" dass 
I molecules are found on the cell surface (2). However, whether 
self-peptides play a specific role in this process or whether 
they serve only to maintain class I H  chains in a particular 
conformation is not clear. 
We sought to develop an in vitro system to test the role 
of class  I binding peptides in CD8 + T  cell development. 
Fetal thymic organ culture (FTOC) provides a way to study 
thymic selective events in vitro (3). In FTOC, the immature 
T  cells present in the thymus at gestational age day 16 de- 
velop in the undisrupted lobe. Assessment of the phenotype 
of the cells over time in this system suggests that develop- 
ment in vitro mimics that in vivo, and that functional T calls 
can be obtained (4). Because class I molecules with sdf-peptides 
are present in lobes from normal animals, we have used thymic 
lobes from mice deficient in fl2M (5, 6).  These mice have 
low surface levels of class I because the H  chains alone are 
not efficiently  transported. As a result, these mice profoundly 
lack CD8 §  mature T  cells.  It has been shown previously 
that despite the low levels of surface class I in APCs lacking 
32M, T cells can recognize them if specific peptide and ~/2M 
are provided exogenously (7).  We have therefore provided 
exogenous class I binding peptides and a source of jF2M and 
assessed CD8 + T  cell development in FTOC. 
Materials and Methods 
Animals.  Time-mated C57BL/6 females were purchased from 
Simonsen (Gilroy, CA).  H-2 b/~M-/-  mice (5) were obtained 
from Beverly Kohler (University of North Carolina, Chapd Hill, 
NC) and maintained in our animal facilities. The day the animals 
were plugged was considered day 1. 
Peptides.  Octamer (OVA 257-264) or nonamer (influenza nu- 
cleoprotein 366-374) class I binding peptides were synthesized on 
a synthesizer (model 430A; Applied Biosystems Inc., Foster City, 
CA) at the Howard Hughes Chemical Synthesis facility, Univer- 
sity of Washington. Acid extracts of spleen were prepared as de- 
scribed (8). Briefly, C57BL/6 spleens were homogenized and then 
sonicated in 0.1% TFA. The material was filtered through a 10-kD 
cutoff membrane (Amicon, Beverly, MA), lyophilized, and resus- 
pended in PBS. 
Random peptide mixtures were synthesized in Escherichia coli as 
described  using a fusion protein purification  strategy (9). A self-prim- 
ing degenerate oligonucleotide (encoding IEGRSXIXFXXL*** 
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BamHI and PstI, and cloned into the BamHI and PstI sites of the 
pMAL-c vector (New England Biolabs Inc., Beverly, MA). Pools 
of clones  were grown to 0.50D~  followed by a 3-h isopopyl 
~-D-thiogalactoside  induction. Fusion proteins were purified by 
affinity chromatography, and the COOH-terminal octameric pep- 
tides released by factor X, cleavage after the IEGIL site. After pas- 
sage through a 10-kD cutoff membrane, this material was further 
purified by HPI.C fractionation on a C18 column (Millipore Corp., 
Milford,  MA).  Peptide-containing  fractions  were  lyophilized, 
resuspended  in PBS, and pooled. Total protein concentration was 
determined by the BCA assay (Pierce,  Rockford, IL). 
FTOC.  Thymuses from day 16 fetal mice were placed on cel- 
lulose ester filters (Millipore Corp.) resting on Gelfoam sponges 
(Upjohn, Kalamazoo, MI) in a 6-well plate. Sponges and filters were 
prewet  in  culture  medium  (RPMI  1640,  1%  Nutridoma  SP 
[Boehringer Mannheim, Indianapolis,  IN],  1 mM sodium pyru- 
vate, 0.1 mM nonessential amino acids, 5  x  10 -5 M 2-ME, 2 mM 
r-glutamine, and 100/~g/ml each of penicillin and streptomycin) 
with or without 10% FCS (Hyclone Laboratories, Logan, UT) and 
peptides. The dishes were kept at 7% COz in a humidity chamber 
at 37~  for 10 d, during which time the media was replenished 
every other day. Lobes were harvested by pressing through a steel 
mesh. Typical cell yields were 5  x  10S/lobe. 
Flow Cytometry.  Thymocytes from adult mice or FTOC were 
stained with the following reagents: PE-L3T4, anti CD4; FITC- 
53.6.7, anti CD8 (both from Becton Dickinson & Co., Mountain 
View, CA); biotin or FITC H57-597, anti TCR-cdB (gift of P. 
Fink, University of Washington,  Seattle, WA); tri-color streptavidin 
(Cahag  Laboratories,  San  Francisco,  CA);  Y3,  anti  Kb;  and 
28.14.8,  anti D b (both from American Type Culture Collection, 
Rockville,  MD)  were  detected  with  FITC  goat  anti-mouse 
IgG,  M,A (Cappel Laboratories,  West Chester, PA). Samples were 
analyzed using a FACScan  |  (Becton Dickinson & Co.). After gating 
on live cells by forward and side angle scatter,  100,000 events were 
collected. 
CTL Assays.  Blast cells were prepared by culturing spleen cells 
with Con A (2.5  #g/ml) and LPS (1 /~g/ml)  for 2 d in AIM-V 
serum-free medium (Gibco, Grand Island, NY). They were labeled 
with SlCr-sodium  chromate and pulsed with OVA 257-264  pep- 
tide in the presence or absence of 10% FCS as a source of/32M 
before use as targets for the OVA plus H-2K  b specific CTL clone 
GA4. 
Results and Discussion 
T  Cells Recognize Peptide Antigen on ~2M-de.ficient Cells. 
In the class I  antigen presentation pathway,  a trimolecular 
complex of dass  I  H  chain,  B2M,  and peptide  are formed 
in the endoplasmic reticulum and efficiently transported to 
the call  surface.  In cdls  lacking  B~M this  complex is not 
formed and H  chain expression on the cell surface is greatly 
impaired  (2,  10,  11).  Tumor cells deficient in/~2M  cannot 
present endogenously produced viral antigens but they are 
able to present peptide antigens when the peptide is supplied 
exogenously with B~.M (7). To directly compare the ability 
of ~2M-deficient and wild type cells to present peptide an- 
tigens, we titrated the natural peptide epitope for an OVA- 
specific CTL. Fig. 1 shows CTL recognition of H-2  b targets 
from either  normal  mice or mice deficient in/32M.  Both 
cells can be targets for CTL after pulsing with a K b binding 
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Figure  1.  Sensitivity of ~2M deficient cells to CTL in the presence of 
peptides and B2M. Lymphobhsts from C57BL/6 or B2M-/-  mice were 
incubated with various concentrations of OVA 257-264 peptide, in the 
presence or absence of FCS as a source of exogenous BzM. Cells were in- 
cubated for 1 h at 37~  in the presence  of SlCr. After washing, GA4 CTL 
were added. Specific  lysis was determined after 4 h. Serum-free  medium 
was used at every step except where indicated. 
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Figure 2.  Adult,  neonatal, and FTOC thymocytes from 32M-/- 
animals are deficient in mature CD8 + T cells. (.4 and 8) Aduh thymo- 
cytes were stained for CD4 and TCR-cd3. TCR-~/3 staining (x-axis) 
and CD4 staining (y-axis) are presented on a logarithmic scale. (C and 
D) Thymocytes recovered  from FTOC. (E) Neonatal (day 3) thymocytes 
from 32M-/-  mice. Each panel is from an individual animal, and is rep- 
resentative of at least three animals in each group. 
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do  not  require  the  addition  of FCS,  whereas  the  /~2M- 
deficient cells do. Under these conditions, the concentration 
of peptide required  for 50% lysis of/32M-deficient cells is 
about 100-fold more than for wild type cells. Purified human 
fl2M atso provided targeting  (data not shown). 
CD8  Development Is Altered in  FTOC  of ~zM-deficient 
Mice.  The  above data  shows that  BzM-ddicient  cells  can 
present exogenous peptide antigen to T cells when provided 
with/3zM.  We reasoned that  CD8 development in FTOC 
from  these  mice  might  then  be  susceptible  to  alteration 
by addition  of exogenous peptide in the presence of fl2M. 
First  it  was necessary to determine  whether  FTOC  from 
/32M-/-  mice showed a block in CD8 + development. Fig. 
2, A  and B shows FACS  |  profiles of TCR and CD4 expres- 
sion in adult thymuses of normal  and B~M-/-  mice.  As 
was previously shown,  these mice are profoundly deficient 
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Figure  3.  Effect  of class I MHC binding peptides on/~2M-/-  FTOC. 
/~2M-/-  lobes were cultured for 10 d in the following: (A) serum free 
medium (SFM) alone; (B) SFM plus 10% FCS; (C) SFM plus 10% FCS 
plus 100 #g/ml each OVA 257-264 (K  b binding) and Flu nucleoprotein 
366-374 (D  b binding) Ix'prides; (D) SFM plus the above  peptides, but with 
no FCS; and (E) SFM plus 10% FCS plus 200 pg/ml listeriolysin-O 211- 
219 peptide (no K  b or D  b binding). Thymocytes  recovered  from FTOC 
lobes were stained as in Fig. 2. The number in the lower fight corner 
is the percentage of CD4-,TCR  hi cells in the boxed area. 100,000 cells 
were analyzed per sample. Each dot represents three cells. 
in  CD8 +,CD4- ,TCR. hi mature  T  calls.  Likewise,  thyrnic 
lobes from these strains  (Fig.  2,  C  and/9)  develop similar 
profiles after 10 d in culture. This indicates that the CD8 + 
cells of mature phenotype which develop in this culture system, 
are in fact the result of positive sdection on class I molecules. 
Other investigators have suggested that cells with a mature 
phenotype can develop in the embryonic thymus in the ab- 
sence of a positive selecting signal (12,  13). Our data argue 
that  this is not  the case. 
Though  the  mutant  mice  show a deficiency of mature 
CD8 + T cells in FTOC (Fig.  2 C), it is not as severe as in 
adult mice (Fig.  2 A).  For example,  the CD8 + to CD4 + 
ratio amongst TCPx hi cells in adult B2M-/-  mice is 0.01, 
whereas in FTOC it is 0.03. This threefold difference is small 
but highly reproducible, and is not due to comparing adult 
to  fetal thymuses,  since 3-d-old  (roughly  age matched  to 
FTOC)  mice have a mature CD8/4  ratio of 0.015 (Fig.  2 
E).  What factors allow for this slightly greater CD8 + de- 
velopment in vitro as compared to in vivo is not  known. 
Class I Binding Peptides Affect CD8 + Development only in 
the Presence ofl~zM.  Next we asked whether class I binding 
peptides added to these cultures  could effect CD8 + devel- 
opment. For all of these experiments the basal medium was 
serum free. Thymic lobes from normal mice developed iden- 
tically in this medium compared to medium containing 10% 
FCS (data not shown).  Fig. 3 shows that  with lobes from 
fl2M-/-  mice, no difference was seen when 10% FCS was 
included in the medium  (compare Fig.  3, A  and B). 
When  class  I  binding  peptides  (in  this  experiment  100 
/xg/ml  each  of a  K b binding  octamer  and  a  D b binding 
nonamer) were included, a small increase was seen in the ma- 
ture CD8 + subset (Fig.  3 C). There was no change seen in 
the other subsets.  In comparing between experiments,  the 
overall extent of T cell development can vary. To control for 
this  we have  compared  the  CD8  to  CD4  ratio  amongst 
TCR  hi cells.  In four experiments,  the mean ratio was .030 
+  .002 when cultured with FCS alone, .046  _+  .012 when 
cultured with peptide and FCS. This increase was dependent 
on the addition of fl~M (Fig.  3 D) and an equivalent con- 
centration of a peptide which does not bind H-2b class I mol- 
ecules had no effect, even in the presence of B2M (Fig. 3 E). 
These data demonstrate that positive selection is dependent 
on class I binding  peptides. 
Complex Mixtures of  Peptides  Are More Efficient.  Although 
single peptides are sufficient to sensitize/32M-deficient  tar- 
gets  for CTL,  and  to  cause  some CD8 +  development  in 
FTOC, they may not provide high enough levels of conforrned 
class I complexes to mediate this selective event efficiently. 
Alternatively, it is possible that  single peptides could never 
select the entire TCR repertoire, and that a complex mixture 
of peptides is required. To test this hypothesis, we added a 
mixture of peptides to FTOC. As a source of heterogenous 
class I binding peptides we used the low molecular weight 
material  from an acid extract  of spleen cells.  Fig.  4  shows 
that this material is considerably more effective in inducing 
CD8 + development than are single peptides. The data is ex- 
pressed as the ratio of CD4 single positive (SP) to CD8 SP 
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Figure  4.  Effect of peptide extracts on ~2M-/-  FTOC. Lobes from 
/~2M-/-  mice were cultured for 10 d in medium with 10% FCS and 
a mixture of OVA 257-264 and Flu nudeoprotein 366-374 or an acid ex- 
tract from C57BL/6 spleen, each at a final concentration of 200/~g/ml. 
Thymocytes recovered from the lobes were stained as in Fig.  2. Data are 
expressed as the ratio of CD8*  to CD4 + cells amongst the TCR  hi cells 
of three to four pooled lobes in each group. The experiment was repeated 
four times with similar results. 
amongst TCR  hi cells. If we consider the total yield of cells 
per lobe in this particular experiment, the yield of CD4 SP 
mature cells per lobe was 8.9  x  104 in the control and 8.5 
x  104 in the presence of the acid extract, whereas the yield 
of CD8 SP mature ceils went from 2.6  x  103 to 8.7  x  103. 
Though the total protein concentration in the acid extract 
is equivalent to the amount of single peptides used, the con- 
centration of class I binding peptides in the acid extract is 
presumably a small percentage of that.  Despite the overall 
lower amount of class I binding peptides in the acid extract 
as compared to single peptides, there is a greater effect on 
CD8 + sdection. This effect was reduced by 70% when no 
BzM was added. 
The extract in Fig. 4 is from C57BL/6 spleen.  However, 
extracts from BALB/c spleen are equally effective at medi- 
ating CD8 + development (data not shown). This may be 
due to the contribution of non-MHC bound peptides that 
are generated during the acid extraction protocol or to pep- 
tides that are shared by MHC alldes. 
To further investigate whether peptide complexity was a 
critical component of CD8 + development, we used a recom- 
binant system for generating class I binding peptides. Heter- 
ogenous octamer peptides were produced in E. coli as a fu- 
sion protein with maltose binding protein. The degenerate 
oligonudeotide used to generate this library encoded pep- 
tides of the following composition: SXIXFXXL, where X 
is any of 20 amino acids. These peptides have the K b anchor 
residues conserved while varying the residues predicted to 
contact the TCR. By using various numbers of colonies to 
begin the preparation, we controlled the heterogeneity of the 
peptide mixture produced. Mixtures consisting of an esti- 
mated 200, 2,300, or 27,000 K b binding peptides were pro- 
duced and purified on reverse phase HPLC.  To assess how 
well these peptide mixtures bound K b we used the RMA-S 
stabilization assay (14) and found that the resultant mixtures 
were as effective as single H-2K  b octamer peptides at binding 
to K b (data not shown). These mixtures were then tested 
for their ability to mediate CD8 + development in BzM-/- 
FTOC. Fig. 5 shows that mixtures of greater complexity are 
more efficient at mediating CD8 development than those of 
lower complexity. The highest concentration of peptides used 
in this experiment was 2.5/~g/ml, almost 100-fold lower than 
that used with single peptides. At this concentration, no de- 
velopment was seen with the single peptides used in Fig. 3 
(data not shown). The enhancement of CD8 + maturation 
was entirely dependent on exogenous B2M (Fig.  5). 
These data show that the induction of CD8 + T  cell de- 
velopment is more efficient on a mixture of class I-peptide 
complexes  and  suggest  that  TCRs  require  specific  sdf- 
peptide/MHC ligands to be positively selected. This has been 
suggested in previous experiments in which it has been shown 
that in TCR transgenic mice (15) or in normal mice (16) 
positive sdection of a specific TCR or a specific response to 
foreign antigen can be disrupted by using K b molecules with 
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Figure  5.  Effect of recombinant peptide mixtures of 
varying complexity  on tSzM-/-  FTOC. FTOC was per- 
formed as described above. Octamer mi~s of various com- 
plexities were purified by HPLC and added at a final con- 
centration of 2.50 or 0.25/~g/ml with or without FCS. 
Data are expressed as the ratio of CD8 + to CD4 + cells 
amongst the TCR  ~ cells of two to four pooled lobes. A 
repeat experiment gave similar results. 
1472  Peptide-dependent CD8 Development In Vitro changes that are thought to affect only the peptide binding 
groove.  Of ultimate interest is  the nature of a  positively 
selecting ligand for a given TCR and how that MHC-self- 
peptide complex is related to the MHC-foreign peptide corn- 
plex. This model system will be useful in identifying pep- 
tides that can mediate positive but not negative selection in 
TCR transgenic mice. 
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